Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder

Código QR

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder

BackgroundUrothelial carcinoma of the bladder (UCB) is a common cancer of the urinary system. Despite substantial improvements in available treatment options, the survival outcome of patients with advanced UCB is unsatisfactory. Therefore, it is necessary to identify new prognostic biomarkers for mo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu Li, Keying Zhang, Fa Yang, Dian Jiao, Mingyang Li, Xiaolong Zhao, Chao Xu, Shaojie Liu, Hongji Li, Shengjia Shi, Bo Yang, Lijun Yang, Donghui Han, Weihong Wen, Weijun Qin
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	PSMA CD248 urothelial carcinoma of the bladder prognosis angiogenesis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/fc57cfb44040442b8f50e32af516e52f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Lymphoepithelioma-Like Carcinoma of Urinary Bladder with Diagnostic Dilemma: Case Report of A Rare Variant of Urothelial Carcinoma
por: Swati Saini, et al.
Publicado: (2021)

Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma
por: Takarn Itsaranujareankul, et al.
Publicado: (2021)

Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity
por: Charles T. Lutz, et al.
Publicado: (2021)

A brief review and case report of urothelial carcinoma and metachronous leiomyosarcoma of the bladder at the same anatomic region
por: Yajie Li, et al.
Publicado: (2022)

FUT7 Promotes the Epithelial–Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma
por: Liu M, et al.
Publicado: (2021)

The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy
por: Tsu-Ming Chien, et al.
Publicado: (2021)

PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma
por: Liu M, et al.
Publicado: (2021)

GATA3 and CK5/6 Immunohistochemical Expression in Urothelial Carcinoma: Diagnostic, Biological and Prognostic Significance
por: Marwa Abdel Moneim El Kholy, et al.
Publicado: (2021)

LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis
por: Wen-Su Wei, et al.
Publicado: (2021)

Radical Cystectomy for Intradiverticular Bladder Carcinoma: A Case Report
por: Anil Kumar Sah, et al.
Publicado: (2021)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Maximilian A. Kirchner, et al.
Publicado: (2021)

YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1
por: Mingran Zhang, et al.
Publicado: (2021)

Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
por: Hanane Lahnif, et al.
Publicado: (2021)

Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions
por: Jaromir Hacek, et al.
Publicado: (2021)

Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog
por: Emmanuelle Marie Butty, et al.
Publicado: (2021)

Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer
por: Chengcheng Wei, et al.
Publicado: (2021)

Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder – An Enigmatic Entity with Poor Prognosis
por: Mayank Kumar, et al.
Publicado: (2021)

Initial Experience of Clinical Use of [<sup>99m</sup>Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
por: Jarosław B. Ćwikła, et al.
Publicado: (2021)

A review on the evolution of immunotherapy in bladder carcinoma
por: Milena Gulinac, et al.
Publicado: (2020)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Kristin A. Plichta, et al.
Publicado: (2021)

Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice
por: Mencinger Marina, et al.
Publicado: (2021)

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: David J. Benjamin, et al.
Publicado: (2021)

Inverted urothelial papilloma: A case report
por: Raj A. Kumar, et al.
Publicado: (2022)

Adult pulmonary blastoma in an adult with urothelial cancer: A case report
por: Shailesh Kolekar, et al.
Publicado: (2021)

Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
por: Shuo Hong, et al.
Publicado: (2021)

(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder
por: Gorka Larrinaga, et al.
Publicado: (2021)

Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas
por: Utpal Kumar, et al.
Publicado: (2021)

Prognostic Effect of Preoperative Psoas Muscle Hounsfield Unit at Radical Cystectomy for Bladder Cancer
por: Yusuke Sugino, et al.
Publicado: (2021)

Calcaneal acrometastasis from urothelial carcinoma of the ureter: a case report and literature review
por: Ryder JH, et al.
Publicado: (2013)

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
por: Xiaodi Zhang, et al.
Publicado: (2021)

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial
por: Bastiaan M. Privé, et al.
Publicado: (2021)

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients
por: Paola Mapelli, et al.
Publicado: (2021)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Guangdi Chu, et al.
Publicado: (2021)

Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers
por: Rizzo M, et al.
Publicado: (2021)

68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors
por: Heying Duan, et al.
Publicado: (2022)

Expression Analysis and Mutational Status of Histone Methyltransferase <i>KMT2D</i> at Different Upper Tract Urothelial Carcinoma Locations
por: Ekaterina Laukhtina, et al.
Publicado: (2021)

Retroperitoneoscopic proximal ureter resection and ureteroureterostomy as an alternative management for upper tract urothelial carcinoma: A case report
por: Agus Rizal AH Hamid, et al.
Publicado: (2022)

PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study
por: Fu-Shun Hsu, et al.
Publicado: (2021)

Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
por: Florestan J. Koll, et al.
Publicado: (2021)

Comparison of <sup>68</sup>Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
por: Julien Van Damme, et al.
Publicado: (2021)